Find a Top Oncologist Near Me – Book an Appointment Instantly

Rezwan Chowdhury, MD is dual board certified by the American Board of Radiology, and The Royal College of Physicians and Surgeons (Canada), in Radiation Oncology. He completed his residency and Medical Doctorate at the Cross Cancer Institute in Edmonton, Alberta, Canada. He has a special interest in breast cancer, lung cancer, SBRT, brachytherapy, PLUVICTO, LUTATHERA, and treats all tumor sites.

Dr. Chowdhury is fellowship trained in brachytherapy, including all modalities of breast brachytherapy.  He has specialized training and is experienced in treating lung cancer, brain metastases and oligo-metastases using SBRT/SRS techniques. Dr. Chowdhury has over 5 years of clinical academic experience at the University of British Columbia/BC Cancer Agency, where he was a clinical instructor to medical students, residents and fellows and served as the Chair of the SBRT program, thoracic tumor site and breast brachytherapy program. Dr Chowdhury has extensive research experience and has published his findings and presented to other specialty physicians around the world.

Dr. Chowdhury joined Arizona Center for Cancer Care in 2021 and has been treating patients throughout the Phoenix metro area for nearly a decade. Dr. Chowdhury believes in using evidenced based medicine, and a compassionate approach that places an emphasis on his patient’s individual needs and desires.

Patient Reviews:

"Very knowledgeable and very good with patients, taking time to fully inform about options." -Ed

"Dr. Chowdhury explains all procedures and treatments thoroughly and takes time to answer any questions the patient may have prior and during treatment." -Ralph

Rezwan Chowdhury, MD is dual board certified by the American Board of Radiology, and The Royal College of Physicians and Surgeons (Canada), in Radiation Oncology. He completed his residency and Medical Doctorate at the Cross Cancer Institute in Edmonton, Alberta, Canada. He has a special interest in breast cancer, lung cancer, SBRT, brachytherapy, PLUVICTO, LUTATHERA, and treats all tumor sites.

Dr. Chowdhury is fellowship trained in brachytherapy, including all modalities of breast brachytherapy.  He has specialized training and is experienced in treating lung cancer, brain metastases and oligo-metastases using SBRT/SRS techniques. Dr. Chowdhury has over 5 years of clinical academic experience at the University of British Columbia/BC Cancer Agency, where he was a clinical instructor to medical students, residents and fellows and served as the Chair of the SBRT program, thoracic tumor site and breast brachytherapy program. Dr Chowdhury has extensive research experience and has published his findings and presented to other specialty physicians around the world.

Dr. Chowdhury joined Arizona Center for Cancer Care in 2021 and has been treating patients throughout the Phoenix metro area for nearly a decade. Dr. Chowdhury believes in using evidenced based medicine, and a compassionate approach that places an emphasis on his patient’s individual needs and desires.

Patient Reviews:

"Very knowledgeable and very good with patients, taking time to fully inform about options." -Ed

"Dr. Chowdhury explains all procedures and treatments thoroughly and takes time to answer any questions the patient may have prior and during treatment." -Ralph

Dr. Justin Famoso specializes in radiation oncology treating a wide variety of malignant and benign diseases with innovative radiation technologies. He promotes continuity of care and emphasizes a multidisciplinary approach in his practice.

Dr. Famoso specializes in the treatment of malignancies of the breast, prostate, lung, head and neck, gynecologic tract, gastrointestinal tract, skin, central nervous system, hematologic/lymphatic systems, and musculoskeletal systems. He has extensive training with modern radiation treatment technologies and techniques including external beam radiation therapy, IMRT, SBRT, PLUVICTO, and brachytherapy.

Dr. Famoso has authored numerous research articles focused on the combination of immunotherapy and radiation therapies leading to improved patient outcomes. 

He earned a B.S. degree from West Virginia University with a double major in biology and chemistry. He went on to receive his M.D. from West Virginia University before completing his internship at the University of Pittsburgh Medical Center. He completed his radiation oncology residency training at the University of Arizona, where he would ultimately serve as chief resident.

Dr. Famoso enjoys golfing, skiing, playing piano, traveling, and viticulture. He is also a passionate West Virginia University Mountaineers sports fan.

Patient Reviews

"I love Dr Famoso and his entire office staff! They are all very caring and attentive. Listens and provides answers and/or options. Highly recommend!!!" -Tamis

"Dr. Famoso and his staff took such good care of me and are so kind and supportive. I look forward to seeing them always. I could not be in in better hands. Thanks so much!" -Davis

Physician Spotlight

About Dr. Dhillon:

Dr. Dhillon is fellowship trained in Hematology and Medical Oncology. His clinical interests include a broad spectrum of disorders including solid tumors, hematologic malignancies, and benign hematologic disorders. His special interests include pancreatic cancer, breast cancer, myeloma, lymphoma, gastrointestinal malignancies, prostate cancer, and lung cancer. Dr. Dhillon also specializes in treatment of blood disorders.

Dr. Dhillon has participated in a number of research projects. He has presented his work at national meetings, and published in journals, including the New England Journal of Medicine.  

He is an advocate of collaborative and patient-centered cancer care that delivers effective treatment while maintaining quality of life.

Dr. Dhillon enjoys golf, writing, activities related to personal fitness, hiking, traveling, and spending time with friends and family.

Patient Reviews:

"I am a snowbird and had no idea who would be a good oncologist during the winter to treat me. When I read about him online, he was one of my top choices and I’m glad I picked him. He has been the perfect fit for me. Not only does he have a friendly personality, but he is very thorough and caring. He is also very efficient as well. If he says he will do something, you can depend on him to do it. I feel that I am in very good hands here. Thank you Dr. Dhillon! I will tell my Idaho friends about you." -Marilyn

"When I come to Dr Dhillon’s office I can honestly say that I have never felt so loved and cared for in any physician’s office. The staff there is excellent beginning with checking in. They are so polite and helpful. All of the nurses take a personal interest to aid me to get my most outstanding care. The encouragement I get from all of them is phenomenal!
I may come in down and dejected but by the time I leave I feel like there is a bright light at the end of the tunnel!!" [click the link below to read the rest] -Linda

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. DiPasquale is a specialized breast surgeon with expertise in treating both malignant and benign breast diseases. Her passion lies in advanced oncoplastic reconstructive surgery, where she combines oncological principles with plastic surgery techniques. She strives to ensure excellent oncological outcomes while also prioritizing cosmetic results and patient satisfaction.

Originally from the east coast of Canada, Dr. DiPasquale completed her medical training at Dalhousie University. Following this, she pursued her General Surgery Residency at the University of Alberta. During her residency, she also earned a Master of Science degree at the prestigious Harvard T.H. Chan School of Public Health, where her research was recognized with an award from the Canadian Federation of University Women.

To further refine her skills and broaden her expertise, Dr. DiPasquale completed a breast oncoplastic and reconstruction surgery fellowship at the renowned Paris Breast Center. She is proud to hold board certifications from both the Royal College of Physicians and Surgeons of Canada and the American Board of Surgery.

Dr. DiPasquale's contributions extend beyond her clinical practice. She has co-authored numerous research papers and actively presents her work at international conferences. Additionally, she serves as a peer reviewer for international journals.

Outside of her professional endeavors, Dr. DiPasquale cherishes quality time spent with her loved ones, including her family, friends, and her beloved Yorkie. After escaping the cold Canadian winters, she also enjoys spending time outdoors in the warm Arizona sun.

Dr. DiPasquale is a specialized breast surgeon with expertise in treating both malignant and benign breast diseases. Her passion lies in advanced oncoplastic reconstructive surgery, where she combines oncological principles with plastic surgery techniques. She strives to ensure excellent oncological outcomes while also prioritizing cosmetic results and patient satisfaction.

Originally from the east coast of Canada, Dr. DiPasquale completed her medical training at Dalhousie University. Following this, she pursued her General Surgery Residency at the University of Alberta. During her residency, she also earned a Master of Science degree at the prestigious Harvard T.H. Chan School of Public Health, where her research was recognized with an award from the Canadian Federation of University Women.

To further refine her skills and broaden her expertise, Dr. DiPasquale completed a breast oncoplastic and reconstruction surgery fellowship at the renowned Paris Breast Center. She is proud to hold board certifications from both the Royal College of Physicians and Surgeons of Canada and the American Board of Surgery.

Dr. DiPasquale's contributions extend beyond her clinical practice. She has co-authored numerous research papers and actively presents her work at international conferences. Additionally, she serves as a peer reviewer for international journals.

Outside of her professional endeavors, Dr. DiPasquale cherishes quality time spent with her loved ones, including her family, friends, and her beloved Yorkie. After escaping the cold Canadian winters, she also enjoys spending time outdoors in the warm Arizona sun.

A licensed and certified physician assistant, Perry has worked in a variety of healthcare settings throughout her career and particularly enjoys working alongside Dr. Brenda Moorthy at the Virginia G Piper Cancer Care Network Comprehensive Breast Center of Arizona. Perry holds a bachelor's degree from the University of Arizona and a Master of Medical Science in Physician Assistant Studies from Midwestern University.

Perry works closely with patients both in the office and during surgery. She is passionate about patient education and makes sure patient questions are always answered.

When Perry is not caring for patients, she loves spending time with her husband, two children, and Boston Terrier. She also enjoys camping, swimming, traveling, and especially, shopping!

A licensed and certified physician assistant, Perry has worked in a variety of healthcare settings throughout her career and particularly enjoys working alongside Dr. Brenda Moorthy at the Virginia G Piper Cancer Care Network Comprehensive Breast Center of Arizona. Perry holds a bachelor's degree from the University of Arizona and a Master of Medical Science in Physician Assistant Studies from Midwestern University.

Perry works closely with patients both in the office and during surgery. She is passionate about patient education and makes sure patient questions are always answered.

When Perry is not caring for patients, she loves spending time with her husband, two children, and Boston Terrier. She also enjoys camping, swimming, traveling, and especially, shopping!

Robin is a certified nurse practitioner at the Arizona Center for Cancer Care, working alongside Dr. Parmjeet Banghar.  She obtained her Bachelor of Science in Nursing at Ameritech College of Nursing in Draper, Utah, and completed her Master of Nursing at Grand Canyon University, as an Acute Care Nurse Practitioner, with an emphasis on Adult Gerontology.   

Prior to becoming a nurse practitioner, Robin worked as a registered nurse for Virginia G. Piper Cancer Care.  Having extensive experience working in oncology/hematology, she understands the importance of providing a patient-centered approach.  Robin is passionate about providing individualized treatment plans and promoting patient advocacy.  

In her spare time, Robin enjoys spending time with her family. She has three adult children, two boys, Gabriel and Rowan, and one daughter Baylee.  She also has an Aussiedoodle, named Bajie. She loves to travel, explore the outdoors, and on occasion play a round of golf.

Dr. Modasi is a highly trained minimally invasive and robotic surgeon with subspecialty expertise in hepatobiliary and pancreatic surgery. He has been published and cited in numerous journals internationally and has given talks to surgeons from across the world.

During his training Dr. Modasi won several awards for his technical abilities in laparoscopy and was ranked amongst the highest trainees across the country academically. He then went on to pursue fellowship training at the University of Alberta focusing on Minimally Invasive Surgery and Bariatric Surgery, followed by a second fellowship in Robotic and Hepatopancreatobiliary (HPB) Surgery at AdventHealth Tampa.

Dr. Modasi specializes in using minimally invasive approaches to treat patients, resulting in less pain and quicker recovery. He has expertise in advanced laparoscopy and the da Vinci robotic system, and utilizes these modalities whenever possible to improve the care of his patients. His clinical interests include hepatobiliary and pancreatic surgery, gastric surgery, anti-reflux surgery and hiatal hernia surgery. He also performs a broad range of general surgery including colon surgery, hernia surgery, and gallbladder surgery. He is a strong believer in tailored patient care, taking time with each of his patients to listen to their story to identify a care plan that best suits their needs.

Patient Reviews:

"Dr Modasi is very thorough in diagnosing & then explaining his care plan in “layperson” terms. He takes the time to answer questions on the procedure. Dr Modasi will do whatever he can to assure a successful procedure & recovery. I’m thankful for his help with my health issues." -Jeff

Dr. Modasi is a highly trained minimally invasive and robotic surgeon with subspecialty expertise in hepatobiliary and pancreatic surgery. He has been published and cited in numerous journals internationally and has given talks to surgeons from across the world.

During his training Dr. Modasi won several awards for his technical abilities in laparoscopy and was ranked amongst the highest trainees across the country academically. He then went on to pursue fellowship training at the University of Alberta focusing on Minimally Invasive Surgery and Bariatric Surgery, followed by a second fellowship in Robotic and Hepatopancreatobiliary (HPB) Surgery at AdventHealth Tampa.

Dr. Modasi specializes in using minimally invasive approaches to treat patients, resulting in less pain and quicker recovery. He has expertise in advanced laparoscopy and the da Vinci robotic system, and utilizes these modalities whenever possible to improve the care of his patients. His clinical interests include hepatobiliary and pancreatic surgery, gastric surgery, anti-reflux surgery and hiatal hernia surgery. He also performs a broad range of general surgery including colon surgery, hernia surgery, and gallbladder surgery. He is a strong believer in tailored patient care, taking time with each of his patients to listen to their story to identify a care plan that best suits their needs.

Patient Reviews:

"Dr Modasi is very thorough in diagnosing & then explaining his care plan in “layperson” terms. He takes the time to answer questions on the procedure. Dr Modasi will do whatever he can to assure a successful procedure & recovery. I’m thankful for his help with my health issues." -Jeff

Dr. Modasi is a highly trained minimally invasive and robotic surgeon with subspecialty expertise in hepatobiliary and pancreatic surgery. He has been published and cited in numerous journals internationally and has given talks to surgeons from across the world.

During his training Dr. Modasi won several awards for his technical abilities in laparoscopy and was ranked amongst the highest trainees across the country academically. He then went on to pursue fellowship training at the University of Alberta focusing on Minimally Invasive Surgery and Bariatric Surgery, followed by a second fellowship in Robotic and Hepatopancreatobiliary (HPB) Surgery at AdventHealth Tampa.

Dr. Modasi specializes in using minimally invasive approaches to treat patients, resulting in less pain and quicker recovery. He has expertise in advanced laparoscopy and the da Vinci robotic system, and utilizes these modalities whenever possible to improve the care of his patients. His clinical interests include hepatobiliary and pancreatic surgery, gastric surgery, anti-reflux surgery and hiatal hernia surgery. He also performs a broad range of general surgery including colon surgery, hernia surgery, and gallbladder surgery. He is a strong believer in tailored patient care, taking time with each of his patients to listen to their story to identify a care plan that best suits their needs.

Patient Reviews:

"Dr Modasi is very thorough in diagnosing & then explaining his care plan in “layperson” terms. He takes the time to answer questions on the procedure. Dr Modasi will do whatever he can to assure a successful procedure & recovery. I’m thankful for his help with my health issues." -Jeff

Dr. Albert Amini is the founder and President of Arizona Premier Surgery as well as a board-certified General Surgeon with fellowship training in minimally invasive surgery for the liver, pancreas, and bile ducts. After earning his medical degree from Northwestern and completing his surgical internship and residency, Dr. Amini spent an additional year learning about hepatobiliary and pancreatic surgery, along with how to use modern technology to perform effective, minimally invasive surgery. Dr. Amini is board certified by the American College of Surgeons and he is also a member of the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition to a full schedule of patients at Arizona Premier Surgery, Dr. Amini travels abroad to perform surgeries on underserved patients in the Dominican Republic, which has improved his fluency in Spanish.

Dr. Amini has a special interest in pancreas surgery, gastrointestinal (GI) oncology and complex hernia repairs. At Arizona Premier Surgery, some of the surgeries he performs are hepatobiliary and pancreatic surgery, as well as gastrointestinal oncology, and colorectal surgery. Dr. Amini has expertise in the da Vinci® robotic surgical system and advanced laparoscopic surgery. Using laparoscopic and robotic techniques, Dr. Amini is able to perform minimally invasive surgery that needs less recovery time than traditional open surgery. In most cases, the pain and discomfort after surgery is much less for patients after laparoscopic/robotic surgery. Although he has already spent many years studying and practicing surgery, Dr. Amini continues to look for techniques and technology that can improve treatment for his patients at Arizona Premier Surgery.

Arizona Center for Cancer Care is a cancer center without walls, offering the best doctors, best treatments, best technologies, and best research to give patients the best care possible. With offices in Avondale, Chandler, Gilbert, Glendale, Mesa, Phoenix, Scottsdale, Surprise, Anthem, Peoria, Fountain Hills, Wickenburg, Apache Junction, Sun City, Sun City West, Goodyear, Prescott Valley, and Tempe, Arizona, the multi-specialty practice cares for more than 30,000 patients across the Valley.

Arizona Center for Cancer Care specializes in treating many types of cancer, including multiple myeloma, colon, head and neck, breast, skin, and pancreatic, as well as brain cancer, lung cancer, and gastrointestinal cancer. 

The practice uses the most current treatment options available, including various forms of radiation oncology and medical oncology, and hematology. The center also includes experts in gynecologic oncology and breast surgery and has a newly diagnosed breast cancer clinic.

The board-certified radiation oncologists at Arizona Center for Cancer Care use positron emission tomography/computed tomography (PET/CT) imaging to reveal the presence and severity of cancer and create an effective treatment plan.

Dedicated to providing its patients with the most current drugs and therapies available, Arizona Center for Cancer Care participates in multiple clinical trials. 

Cancer is a disease of survivors, and Arizona Center for Cancer Care is keeping it that way.  

For comprehensive, high-quality cancer care, call Arizona Center for Cancer Care or schedule an appointment online today. Telemedicine appointments are available.